Basic Science News at Duke School of Medicine

David Ashley, PhD, FRACP, MBBS, the Rory David Deutsch Distinguished Professor of Neuro-Oncology and director of the Preston Robert Tisch Brain Tumor Center at Duke, calls his choice to focus his career on brain cancers "a compulsion to defeat this terrible problem."  

Colin Duckett, Vice Dean for Basic Science, led a discussion with premier researchers taking a a closer look at the fundamental biology of Parkinson’s disease during the March 30 Dean’s Distinguished Research Series.

Idiopathic pulmonary fibrosis (IPF) is a disease that causes scarring on the lungs. Over time, as more scarring occurs, patients experience decreased lung function and difficulty breathing. Once diagnosed, most patients die within five years. 

Raluca Gordân, PhD, and team investigated how transcription factors may affect the production of genetic mutations, or mutagenesis, by binding to the wrong sites after being exposed to ultraviolet (UV) radiation.

The goal of Shuo Han's research is to understand the interplay between the human gut microbiota and aging.

A Duke study could point to new targets for therapies to prevent or treat anaphylactic shock, which occurs in up to 5% of people in the U.S. annually in response to food allergies or bites from insects or venomous animals.

Graduate students at Duke University who are laying the groundwork for new health care innovations were honored March 1 at the Chancellor’s Award for Research Excellence (CARE) ceremony.

Gift by Marion Stein, MD, to support research and faculty at the Duke Human Vaccine Institute.

Duke University School of Medicine's Dean's Distinguished Research Series kicked off on February 23 with the Robert J. Lefkowitz, MD, Distinguished Lecture by cell biologist Titia de Lange, PhD, of Rockefeller University and faculty lectures from two Duke researchers who study the genes that make us uniquely human.

One in seven men are diagnosed with prostate cancer during their lifetimes. For those who aren't cured by surgery or radiation, treatments that suppress the male hormone androgen can temporarily stop the disease from progressing. But at some point, hormone-based treatments stop working for most men.